Agiliti Inc is a health information services business based in the US. Agiliti shares (AGTI) are listed on the NYSE and all prices are listed in US Dollars. Agiliti employs 4,900 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $21.58 |
|---|---|
| 52-week range | $16.09 - $26.34 |
| 50-day moving average | $19.54 |
| 200-day moving average | $20.27 |
| Wall St. target price | $25.22 |
| PE ratio | 84.0638 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.25 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $21.58 from 2022-07-01
| 1 week (2022-06-24) | 2.27% |
|---|---|
| 1 month (2022-06-02) | 11.99% |
| 3 months (2022-04-01) | 0.98% |
| 6 months (2021-12-31) | -6.82% |
| 1 year (2021-07-02) | 0.94% |
|---|---|
| 2 years (2020-06-28) | N/A |
| 3 years (2019-06-28) | N/A |
| 5 years (2017-06-28) | N/A |
Valuing Agiliti stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Agiliti's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Agiliti's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 84x. In other words, Agiliti shares trade at around 84x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Agiliti's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.
Agiliti's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $313.9 million.
The EBITDA is a measure of a Agiliti's overall financial performance and is widely used to measure a its profitability.
To put Agiliti's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 10.99% |
| Gross profit TTM | $424.6 million |
| Return on assets TTM | 3.22% |
| Return on equity TTM | 4.96% |
| Profit margin | 3.13% |
| Book value | $7.04 |
| Market capitalisation | $2.8 billion |
TTM: trailing 12 months
We're not expecting Agiliti to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Agiliti's shares have ranged in value from as little as $16.091 up to $26.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Agiliti's is 1.0259. This would suggest that Agiliti's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Agiliti's beta into context you can compare it against those of similar companies.
Agiliti, Inc. provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity. It also offers clinical engineering services comprising maintenance, repair, and remediation solutions for various types of medical equipment, including general biomedical equipment, diagnostic imaging equipment, and surgical equipment through supplemental and outsourced offerings. In addition, the company provides equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. As of December 31, 2021, it owned or managed approximately a million units of medical equipment for approximately 9,000 national, regional, and local acute care hospitals, health systems and integrated delivery networks, and alternate site providers. Agiliti, Inc.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.